LF3 exerts anti-osteosarcoma effects through Wnt signaling inhibition-coupled ferroptosis induction via &lt;i&gt;HO-1/ACSL4&lt;/i&gt; axis. The gene discussed is ACSL4; the disease is osteosarcoma.